Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston
boston blog main
boston top stories
deals
life sciences
national blog main
startups
480 biomedical
arsenal medical
azacitidine
beta-thalassemia
bob langer
business
business sponsored company news
chronic rhinosinusitis
clinical trials
covid-19
dacogen
decitabine
dna
drug delivery
epigenetics
epizyme
farydak
fda
flagship pioneering
fulcrum therapeutics
genzyme
george whitesides
inflammation
insulated genomic domains
investing
ipo
kaleido biosciences
keros therapeutics
lyra therapeutics
mahesh karande
medical device
mometasone furorate
What
biotech
3
×
developing
3
×
therapeutics
3
×
company
medicines
million
new
aims
announced
approach
based
breakthrough
called
completion
debut
debuts
dedicated
drugs
epigenetic
epigenetics
field
financing
flagship’s
insights
ipo
late
leveraging
lyra
markets
morning
motion
nose
noses
omega
persistently
press
proceeds
protein
public
raised
Language
unset
Current search:
biotech
×
therapeutics
×
developing
×
@xconomy.com
4 years ago
Lyra Therapeutics IPO Raises $56M for Tests of Tech for Runny Noses
@xconomy.com
4 years ago
Flagship’s Omega Aims to Take Epigenetic Drugs a Step Further
@venturebeat.com
6 years ago
Relay Therapeutics Secures $63 Million in Series B Financing
